Bajorath, Jürgen (2022) Deep Machine Learning for Computer-Aided Drug Design. Frontiers in Drug Discovery, 2. ISSN 2674-0338
Text
pubmed-zip/versions/1/package-entries/fddsv-02-829043/fddsv-02-829043.pdf - Published Version
Download (849kB)
pubmed-zip/versions/1/package-entries/fddsv-02-829043/fddsv-02-829043.pdf - Published Version
Download (849kB)
Official URL: https://doi.org/10.3389/fddsv.2022.829043
Abstract
In recent years, deep learning (DL) has led to new scientific developments with immediate implications for computer-aided drug design (CADD). These include advances in both small molecular and macromolecular modeling, as highlighted herein. Going forward, these developments also challenge CADD in different ways and require further progress to fully realize their potential for drug discovery. For CADD, these are exciting times and at the very least, the dynamics of the discipline will further increase.
Item Type: | Article |
---|---|
Subjects: | Institute Archives > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 27 Feb 2023 04:37 |
Last Modified: | 10 Jul 2024 13:01 |
URI: | http://eprint.subtopublish.com/id/eprint/749 |